Article
The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.
Expert review of clinical pharmacology - 1 Mar 2013
Louie Samuel, Zeki Amir A, Schivo Michael, Chan Andrew L, Yoneda Ken Y, Avdalovic Mark, Morrissey Brian M, Albertson Timothy E
Abstract excerpt
Asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15-25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients with ACOS have the combined risk factors of smoking and atopy, are generally younger than patients with COPD and...
Topics
- Algorithms
- Asthma
- Diagnosis, Differential
- Humans
- Phenotype
- Pulmonary Disease, Chronic Obstructive
- Respiratory System Agents
- Risk Factors
- Smoking
- Smoking Cessation
- Syndrome